4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-20-010614
Chief Financial Officer acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Elefant Dov Chief Financial Officer | 2020-02-03 | Grant or award | +10,000 | $2.71 | $27,100 | 10,000 | D |
Loading xslF345X03/tm206696d2_4.xml…